Excalibur Management Corp Pfizer Inc Transaction History

Excalibur Management Corp

$261 Million
Q3 2024

A detailed history of Excalibur Management Corp transactions in Pfizer Inc stock. As of the latest transaction made, Excalibur Management Corp holds 162,378 shares of PFE stock, worth $4.34 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares

162,378

Previous 164,336 1.19%

Holding current value

$4.34 Million

Previous $4.6 Million 2.2%

% of portfolio

1.8%

Previous 1.88%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $54,236 - $61,461	-1,958 Reduced 1.19%	162,378 $4.7 Million
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $78,053 - $91,464	3,090 Added 1.92%	164,336 $4.6 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $78,343 - $89,962	3,026 Added 1.91%	161,246 $4.47 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $783 - $1,018	-30 Reduced 0.02%	158,220 $4.56 Million
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $124,445 - $145,463	3,878 Added 2.51%	158,250 $5.25 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $27,812 - $32,178	770 Added 0.5%	154,372 $5.66 Million
Q1 2023 May 05, 2023	SELL	$39.39 - $51.28 $1,024 - $1,333	-26 Reduced 0.02%	153,602 $6.27 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $26,845 - $35,043	-643 Reduced 0.42%	153,628 $7.87 Million
Q3 2022 Nov 04, 2022	BUY	$43.76 - $53.42 $64,589 - $78,847	1,476 Added 0.97%	154,271 $6.75 Million
Q2 2022 Jul 25, 2022	SELL	$46.53 - $55.17 $99,713 - $118,229	-2,143 Reduced 1.38%	152,795 $8.01 Million
Q1 2022 May 03, 2022	SELL	$45.75 - $56.69 $40,122 - $49,717	-877 Reduced 0.56%	154,938 $8.02 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $50,038 - $74,173	-1,211 Reduced 0.77%	155,815 $9.2 Million
Q3 2021 Oct 28, 2021	SELL	$39.25 - $50.42 $108,997 - $140,016	-2,777 Reduced 1.74%	157,026 $6.75 Million
Q2 2021 Jul 26, 2021	BUY	$35.91 - $40.68 $105,252 - $119,233	2,931 Added 1.87%	159,803 $6.26 Million
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $173,846 - $196,064	5,191 Added 3.42%	156,872 $5.68 Million
Q4 2020 Jan 26, 2021	SELL	$33.47 - $42.56 $125,512 - $159,600	-3,750 Reduced 2.41%	151,681 $5.58 Million
Q3 2020 Nov 02, 2020	SELL	$31.75 - $37.25 $294,005 - $344,935	-9,260 Reduced 5.62%	155,431 $5.7 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $82,287 - $99,827	2,732 Added 1.69%	164,691 $5.39 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $180,344 - $257,672	6,672 Added 4.3%	161,959 $5.29 Million
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $21,760 - $24,694	-661 Reduced 0.42%	155,287 $6.08 Million
Q3 2019 Oct 21, 2019	BUY	$32.49 - $42.13 $172,911 - $224,215	5,322 Added 3.53%	155,948 $5.6 Million
Q2 2019 Jul 26, 2019	SELL	$36.98 - $41.52 $162,305 - $182,231	-4,389 Reduced 2.83%	150,626 $6.53 Million
Q1 2019 Apr 24, 2019	SELL	$37.5 - $41.2 $73,462 - $80,710	-1,959 Reduced 1.25%	155,015 $6.58 Million
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $180,424 - $205,703	-4,690 Reduced 2.9%	156,974 $6.85 Million
Q3 2018 Oct 25, 2018	SELL	$34.47 - $41.81 $337,633 - $409,528	-9,795 Reduced 5.71%	161,664 $7.13 Million
Q2 2018 Jul 26, 2018	SELL	$32.98 - $35.16 $60,782 - $64,799	-1,843 Reduced 1.06%	171,459 $6.22 Million
Q1 2018 Apr 23, 2018	BUY	$31.91 - $37.02 $21,954 - $25,469	688 Added 0.4%	173,302 $6.15 Million
Q4 2017 Jan 22, 2018	SELL	$33.26 - $35.29 $121,066 - $128,455	-3,640 Reduced 2.07%	172,614 $6.25 Million
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $5.46 Million - $6.02 Million	176,254	176,254 $6.29 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Excalibur Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Excalibur Management Corp with notifications on news.

Account

Excalibur Management Corp Pfizer Inc Transaction History